Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on July 10, 2025

SandStone Partners Health, dba YourMedPlan, Acquires McBride Insurance Agency to Expand Florida Operations

SandStone Partners Health, dba YourMedPlan, Acquires McBride Insurance Agency to Expand Florida Operations

Acquisition expands access to Florida Blue health insurance solutions for individuals, families, and businesses across the greater Orlando area. CLEARWATER, FL, UNITED STATES, July 10, 2025 /⁨EINPresswire.com⁩/ -- SandStone Partners Health, LLC, doing …

Direct Surrender Method: A Safe Haven for Newborns

Direct Surrender Method: A Safe Haven for Newborns

Brings Peace of Mind to the Birth Mother that Her Infant Will be Safe and Cared For MIAMI, FL, UNITED STATES, July 10, 2025 /⁨EINPresswire.com⁩/ -- Surrendering a newborn in the arms of another person reassures the mother her infant will be safe and taken …

Mobility City of Sarasota Delivers Fast, Veteran-Focused Wheelchair & Scooter Repairs Across the Gulf Coast

Mobility City of Sarasota Delivers Fast, Veteran-Focused Wheelchair & Scooter Repairs Across the Gulf Coast

Owner Jamie Houser offers priority wheelchair and scooter repair services for veterans across Florida’s Gulf Coast. Fast, reliable, and respectful service. SARASOTA, FL, UNITED STATES, July 10, 2025 /⁨EINPresswire.com⁩/ -- Mobility City of Sarasota …

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif. , July 10, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on July 6, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 133,500 shares of …

Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension

Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension

Palo Alto, CA, July 10, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced their support for the Centers for Medicare and Medicaid Services’ (CMS) …

OfficeHub Tech Successfully Delivers Enterprise-Grade Zoho One Implementation Across Multi-Clinic Healthcare Network

OfficeHub Tech Successfully Delivers Enterprise-Grade Zoho One Implementation Across Multi-Clinic Healthcare Network

Florida-based consulting firm leads full-scale digital transformation for a growing U.S. medical provider LAKE MARY, FL, UNITED STATES, July 10, 2025 /⁨EINPresswire.com⁩/ -- OfficeHub Tech, a top-rated Zoho consulting and digital solutions firm based in …

Galen College  and HCA Florida Healthcare Celebrate New Orlando Campus

Galen College and HCA Florida Healthcare Celebrate New Orlando Campus

Galen College of Nursing is increasing access to quality nursing education in Central Florida with the grand opening of its new Orlando campus. ORLANDO, FL, UNITED STATES, July 10, 2025 /⁨EINPresswire.com⁩/ -- Galen College of Nursing, a proud affiliate …

NKGen Biotech Administers First Dose of Troculeucel to Alzheimer’s Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy

NKGen Biotech Administers First Dose of Troculeucel to Alzheimer’s Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy

SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …

Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

HUNTSVILLE, AL, July 10, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietary POZ …

Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025

Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025

ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will host a conference call to …

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nasdaq compliance follows positive upward trend in Company’s Stock Price  Jupiter, Florida, July 10, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL …

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy

SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for …

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its previously …

Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer

Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support company’s transformation and growth in autoimmune disease CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a …

Brookdale and Monmouth Medical Center Launch Partnership to Expand Nursing Education and Workforce Pathways

Brookdale and Monmouth Medical Center Launch Partnership to Expand Nursing Education and Workforce Pathways

Lincroft, NJ, July 10, 2025 (GLOBE NEWSWIRE) -- Brookdale Community College and Monmouth Medical Center (MMC) have entered into an agreement to expand educational and career opportunities for aspiring nurses in Monmouth County. The formal partnership …

Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation

Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation

CEO's personal contribution fully funds build-out and first-year operations Doubled HQ footprint centralizes cross-functional teams, including research, regulatory affairs, and the expanding Tevogen.AI initiative WARREN, N.J., July 10, 2025 (GLOBE NEWSWIRE …

Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology

Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology

BLUE BELL, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- Slipstream, a trusted technology partner serving the Pharmaceutical and Biopharmaceutical industry, is proud to announce its co-authorship of a groundbreaking study on Hereditary Hemorrhagic Telangiectasia …

CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years

CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years

Boston, July 10, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Current R…

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service